Listing 1 - 6 of 6 |
Sort by
|
Choose an application
C-peptide --- Insulin --- Proinsulin --- Analysis.
Choose an application
C-Peptide --- Reagent Kits, Diagnostic --- blood
Choose an application
INSULIN --- ISLANDS OF LANGERHANS --- INSULIN --- C-PEPTIDE --- OBESITY --- C-PEPTIDE --- SECRETION --- SECRETION --- BLOOD --- BLOOD --- URINE --- INSULIN --- ISLANDS OF LANGERHANS --- INSULIN --- C-PEPTIDE --- OBESITY --- C-PEPTIDE --- SECRETION --- SECRETION --- BLOOD --- BLOOD --- URINE
Choose an application
C-peptide --- C-peptide. --- Insulin --- Insulin. --- Insulin. --- Insuline --- Peptides --- Peptides. --- Proinsulin --- Proinsulin. --- Proinsulin. --- Proinsuline --- Congrès. --- Congrès. --- Congrès. --- 1978-07-12 --- 1978-07-14. --- Tokushima (Japan).
Choose an application
In Diabetes & C-Peptide: Scientific and Clinical Aspects, a renowned group of leading researchers and physicians offers a comprehensive overview of the role of C-Peptide in type 1 diabetes. The book is organized in five sections. An Introductory section provides the background and key features of C-peptide’s physiological function and how its deficiency contributes to complications. The second section describes up-to-date information on the biochemical and molecular actions of C-peptide, including membrane binding, interactions with insulin as well as the interaction between C-peptide and zinc and effects on microvascular vasoreactivity. The third section summarizes in vivo animal studies of the type 1 diabetic complications. The fourth section reviews the clinical efforts of C-peptide on inflammation, cardiovascular complication, neuropathy and nephropathy. Finally, in the Conclusions section, a summary of the present state of C-peptide, outstanding questions, and the likely direction of the field are offered. Developed by the foremost investigators in the rapidly moving field of C-peptide research, Diabetes & C-Peptide: Scientific and Clinical Aspects is an important contribution to the literature for all researchers and physicians concerned about type 1 diabetes.
C-peptide. --- Diabetes. --- Diabetes -- Complications. --- Diabetes --- C-peptide --- Diabetes Mellitus --- Proinsulin --- Therapeutics --- Autoimmune Diseases --- Biological Science Disciplines --- Analytical, Diagnostic and Therapeutic Techniques and Equipment --- Immune System Diseases --- Pancreatic Hormones --- Endocrine System Diseases --- Glucose Metabolism Disorders --- Natural Science Disciplines --- Peptide Hormones --- Diseases --- Disciplines and Occupations --- Metabolic Diseases --- Peptides --- Nutritional and Metabolic Diseases --- Hormones --- Hormones, Hormone Substitutes, and Hormone Antagonists --- Amino Acids, Peptides, and Proteins --- Chemicals and Drugs --- Physiology --- Diabetes Mellitus, Type 1 --- Drug Therapy --- C-Peptide --- Diabetes Complications --- Medicine --- Health & Biological Sciences --- Clinical Endocrinology --- Complications --- Brittle diabetes --- Diabetes mellitus --- IDDM (Disease) --- Insulin-dependent diabetes --- Ketosis prone diabetes --- Type 1 diabetes --- Connecting peptide --- Medicine. --- Internal medicine. --- Endocrinology. --- Medicine & Public Health. --- Internal Medicine. --- Carbohydrate intolerance --- Endocrine glands --- Diabetic acidosis --- Glycosylated hemoglobin --- Medicine, Internal --- Internal medicine --- Endocrinology .
Choose an application
Nanomedicine represents one of the most investigated areas in the last two decades in the field of pharmaceutics. Several nanovectors have been developed and a growing number of products have been approved. It is well known that many biomaterials are able to self-organize under controlled conditions giving rise nanostructures. Polymers, lipids, inorganic materials, peptides and proteins, and surfactants are examples of such biomaterials and the self-assembling property can be exploited to design nanovectors that are useful for drug delivery. The self-organization of nanostructures is an attractive approach to preparing nanovectors, avoiding complex and high-energy-consuming preparation methods, and, in some cases, facilitating drug loading procedures. Moreover, preparations based on these biocompatible and pharmaceutical grade biomaterials allow an easy transfer from the lab to the industrial scale. This book reports ten different works, and a review, aiming to cover multiple strategies and pharmaceutical applications in the field of self-organizing nanovectors for drug delivery.
chitosan --- encapsulation --- gold nanoparticles --- pH/redox-responsive --- bolaform amphiphilic lipids --- irradiation cycles --- drug delivery --- caries prevention --- bolalipids --- nanocage --- natural extracts --- astaxanthin --- eukaryotic vaults --- nanoparticles --- amphiphilic random copolymers --- zoledronic acid --- triggered release --- nanohydrogels --- doxorubicin --- vapor nanobubbles --- curcumin --- gold reduction --- diffusion barrier --- liposomes --- hyaluronan --- laser treatment --- nanoparticle --- mixed polymeric micelles --- protein self-assembly --- squalene --- antimicrobial photodynamic therapy --- self-assembly --- hydrogel --- C-peptide --- polyelectrolyte complexes --- siRNA delivery --- drug delivery system --- biofilms --- pulmonary surfactant --- multidrug resistance --- drug delivery systems --- nano-assemblies --- photo-thermal therapy --- anticancer --- polypeptides --- graphene quantum dots --- nanovesicles --- aerogel --- resveratrol --- intracellular therapy --- Oral antimicrobials --- syringeable implant --- trehalose --- betulinic acid --- in situ gelling systems --- autophagy induction --- chorioallantoic membrane model --- controlled release --- diabetes --- oxidative stress --- localized heating effect
Listing 1 - 6 of 6 |
Sort by
|